Humabiologics: Funding, Investors & Team (Oct 2026)
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers. Currently, the availability of human-derived biomaterials for regenerative therapies and research is limited due to unstable supply channels, low quality, and high prices. Humabiologics is dedicated to extending the gift of donation by developing and commercializing high quality, supply-stable and affordable human-derived biomaterials from tissue and organs for regenerative medicine therapies that complies with the FDA's 21 CFR 1271 regulation and the tissue industry quality system standards. By stretching the gift of donation we strive to help as many people as possible with our unique products.
Humabiologics has raised $700k across 1 funding round on record, the most recent a Seed of $700k announced in Jan 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Humabiologics Company Profile and Key Stats
Latest funding round on record: Jan 2022.
Humabiologics Funding Rounds
Humabiologics Founders and Leadership Team
Contact details for the Humabiologics team: 1 of 1 has an email address on file.
Start 14-day free trial →Humabiologics Funding Compared to Other Biotechnology Startups
Humabiologics' latest round of $700k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Humabiologics in Biotechnology and Phoenix
Companies Similar to Humabiologics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Humabiologics Funding FAQs
What does Humabiologics do?
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers. Currently, the availability of human-derived biomaterials for regenerative therapies and research is limited due to unstable supply channels, low quality, and high prices. Humabiologics is dedicated to extending the gift of donation by developing and commercializing high quality, supply-stable and affordable human-derived biomaterials from tissue and organs for regenerative medicine therapies that complies with the FDA's 21 CFR 1271 regulation and the tissue industry quality system standards. By stretching the gift of donation we strive to help as many people as possible with our unique products.
How much funding has Humabiologics raised?
Humabiologics has raised $700k across 1 round on record. The most recent is a Seed of $700k announced in Jan 2022.
When did Humabiologics last raise funding?
Humabiologics' most recent funding round on record is a Seed of $700k, announced in Jan 2022.
Who is the CEO of Humabiologics?
Mohammad Albanna is listed as CEO at Humabiologics.
Where is Humabiologics headquartered?
Humabiologics is based in Phoenix, Arizona, United States.
How many employees does Humabiologics have?
Humabiologics is in the 1-10 employee band.
How does Humabiologics' funding compare to other Biotechnology startups?
Humabiologics' latest round of $700k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Humabiologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Humabiologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.